Literature DB >> 11165758

High frequency of homozygous deletion and methylation of p16(INK4A) gene in oral squamous cell carcinomas.

Y Nakahara1, S Shintani, M Mihara, Y Ueyama, T Matsumura.   

Abstract

p16(INK4A) inactivation was analyzed in ten squamous cell carcinoma (SCC) cell lines and 32 primary SCCs, using the polymerase chain reaction (PCR), PCR-single-strand conformation polymorphism, methylation-specific PCR, and cycle sequencing. In the study of cell lines, we detected three deletions in exon 1alpha and exon 2, and detected two methylations. Among tumor samples, we detected the homozygous deletions (HDs) of 43.8% in exon 1alpha 34.4% in exon 2, and methylation was found in 50.0%. The lack of p16(INK4A) with immunohistochemistry was detected in 71.9% and matched the alteration of p16(INK4A) gene. These results suggest that p16(INK4A) inactivation is predominantly caused by HD and methylation, and immunohistochemical evaluation of p16(INK4A) is a useful method.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165758     DOI: 10.1016/s0304-3835(00)00699-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

1.  p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status.

Authors:  James S Lewis; Wade L Thorstad; Rebecca D Chernock; Bruce H Haughey; James H Yip; Qin Zhang; Samir K El-Mofty
Journal:  Am J Surg Pathol       Date:  2010-08       Impact factor: 6.394

Review 2.  Epigenetic mechanisms in oral carcinogenesis.

Authors:  Jacqueline A Gasche; Ajay Goel
Journal:  Future Oncol       Date:  2012-11       Impact factor: 3.404

3.  Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis.

Authors:  Maureen A Sartor; Dana C Dolinoy; Tamara R Jones; Justin A Colacino; Mark E P Prince; Thomas E Carey; Laura S Rozek
Journal:  Epigenetics       Date:  2011-06-01       Impact factor: 4.528

4.  Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma - a prospective cohort and interobserver variability study.

Authors:  James S Lewis; Raja A Khan; Ramya P Masand; Rebecca D Chernock; Qin Zhang; Nasser Said Al-Naief; Susan Muller; Jonathan B McHugh; Manju L Prasad; Margaret Brandwein-Gensler; Bayardo Perez-Ordonez; Samir K El-Mofty
Journal:  Histopathology       Date:  2011-12-23       Impact factor: 5.087

5.  Frequency of genetic and epigenetic alterations of p14ARF and p16INK4A in head and neck cancer in a Hungarian population.

Authors:  Andrea Kis; Tímea Zsófia Tatár; Tamás Gáll; Róbert Boda; Ildikó Tar; Tamás Major; Pál Redl; Lajos Gergely; Krisztina Szarka
Journal:  Pathol Oncol Res       Date:  2014-04-09       Impact factor: 3.201

6.  Aberrant promoter methylation of p16 in colorectal adenocarcinoma in North Indian patients.

Authors:  Pooja Malhotra; Rakesh Kochhar; Kim Vaiphei; Jai Dev Wig; Safrun Mahmood
Journal:  World J Gastrointest Oncol       Date:  2010-07-15

7.  Integrative molecular characterization of head and neck cancer cell model genomes.

Authors:  Ivy F L Tsui; Cathie Garnis
Journal:  Head Neck       Date:  2010-09       Impact factor: 3.147

8.  Differential expression of p16(INK4A) and cyclin D1 in benign and malignant salivary gland tumors: a study of 44 Cases.

Authors:  G Jour; K West; V Ghali; D Shank; G Ephrem; B M Wenig
Journal:  Head Neck Pathol       Date:  2013-01-13

9.  HPV-16/18 detection does not affect the prognosis of head and neck squamous cell carcinoma in younger and older patients.

Authors:  Luciano Marques-Silva; Lucyana Conceição Farias; Carlos Alberto de Carvalho Fraga; Marcos Vinícius Macedo de Oliveira; Cláudio Marcelo Cardos; Thiago Fonseca-Silva; Carolina Cavalieri Gomes; Alfredo Maurício Batista De-Paula; Ricardo Santiago Gomez; André Luiz Sena Guimarães
Journal:  Oncol Lett       Date:  2012-02-01       Impact factor: 2.967

Review 10.  Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications.

Authors:  Chun-Yang Fan
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.